The University of Alabama at Birmingham (UAB) was awarded a $192,433 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The goal of this 5-year project is to increase the use of mainstream genetic testing (MGT) for colorectal cancer (CRC) patients by characterizing barriers and piloting a multi-level implementation strategy tailored to those barriers. The project will assess MGT barriers among non-genetic healthcare providers and institutional stakeholders through qualitative interviews, evaluate patient perceptions using a mixed methods approach, and then pilot a strategy involving provider education, technical assistance, and patient materials at two institutions in Alabama. The findings from this mentored research project will inform a future hybrid effectiveness-implementation trial to scale MGT implementation for CRC patients, supporting the awardee's career development toward becoming an independent cancer health services researcher.
Generated 3/4/25, 5:04 AM